《颅内静脉和静脉窦血栓形成诊治的中国专家共识》解读

2016-12-21 天津市环湖医院神经外科 范一木 中国现代神经疾病杂志.2016,16(1

为推动颅内静脉和静脉窦血栓形成的规范化诊断与治疗、更好地指导神经科医师临床实践,2013 年我国静脉和静脉窦血栓形成诊治的多中心专家共识组制定《颅内静脉和静脉窦血栓形成诊治的中国专家共识》,本文拟对共识的主要内容进行解读。

发布日期:2016-12-06

作者: 天津市环湖医院神经外科 范一木

出处:中国现代神经疾病杂志.2016,16(12):822-825.

对应指南:2013 颅内静脉和静脉窦血栓形成诊治的中国专家共识 静脉和静脉窦血栓形成诊治的多中心专家共识组; 中国神经内科相关专家小组(统称)


内容介绍:

颅内静脉和静脉窦血栓形成是由多种原因导致的一种临床少见脑静脉系统疾病,尤以中青年多见。由于其临床症状复杂,可以表现为头痛、呕吐、癫发作和局灶性神经功能障碍等,极易误诊或漏诊,病残率和病死率均较高。为推动颅内静脉和静脉窦血栓形成的规范化诊断与治疗、更好地指导神经科医师临床实践,2013 年我国静脉和静脉窦血栓形成诊治的多中心专家共识组制定《颅内静脉和静脉窦血栓形成诊治的中国专家共识》,本文拟对共识的主要内容进行解读。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1844687, encodeId=0456184468ef4, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Mon May 22 03:53:00 CST 2017, time=2017-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934383, encodeId=14761934383c1, content=<a href='/topic/show?id=cfab9916818' target=_blank style='color:#2F92EE;'>#静脉窦血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99168, encryptionId=cfab9916818, topicName=静脉窦血栓)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11b4465, createdName=ying_wu, createdTime=Sun Jul 02 19:53:00 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741415, encodeId=ffa71e41415ab, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Sat Aug 19 09:53:00 CST 2017, time=2017-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697403, encodeId=7754169e403d9, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Fri May 12 00:53:00 CST 2017, time=2017-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618547, encodeId=0e20161854ec1, content=<a href='/topic/show?id=a95e9916698' target=_blank style='color:#2F92EE;'>#静脉窦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99166, encryptionId=a95e9916698, topicName=静脉窦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=237819898930, createdName=12498d2fm57(暂无昵称), createdTime=Fri Dec 23 04:53:00 CST 2016, time=2016-12-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1844687, encodeId=0456184468ef4, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Mon May 22 03:53:00 CST 2017, time=2017-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934383, encodeId=14761934383c1, content=<a href='/topic/show?id=cfab9916818' target=_blank style='color:#2F92EE;'>#静脉窦血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99168, encryptionId=cfab9916818, topicName=静脉窦血栓)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11b4465, createdName=ying_wu, createdTime=Sun Jul 02 19:53:00 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741415, encodeId=ffa71e41415ab, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Sat Aug 19 09:53:00 CST 2017, time=2017-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697403, encodeId=7754169e403d9, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Fri May 12 00:53:00 CST 2017, time=2017-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618547, encodeId=0e20161854ec1, content=<a href='/topic/show?id=a95e9916698' target=_blank style='color:#2F92EE;'>#静脉窦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99166, encryptionId=a95e9916698, topicName=静脉窦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=237819898930, createdName=12498d2fm57(暂无昵称), createdTime=Fri Dec 23 04:53:00 CST 2016, time=2016-12-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1844687, encodeId=0456184468ef4, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Mon May 22 03:53:00 CST 2017, time=2017-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934383, encodeId=14761934383c1, content=<a href='/topic/show?id=cfab9916818' target=_blank style='color:#2F92EE;'>#静脉窦血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99168, encryptionId=cfab9916818, topicName=静脉窦血栓)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11b4465, createdName=ying_wu, createdTime=Sun Jul 02 19:53:00 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741415, encodeId=ffa71e41415ab, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Sat Aug 19 09:53:00 CST 2017, time=2017-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697403, encodeId=7754169e403d9, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Fri May 12 00:53:00 CST 2017, time=2017-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618547, encodeId=0e20161854ec1, content=<a href='/topic/show?id=a95e9916698' target=_blank style='color:#2F92EE;'>#静脉窦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99166, encryptionId=a95e9916698, topicName=静脉窦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=237819898930, createdName=12498d2fm57(暂无昵称), createdTime=Fri Dec 23 04:53:00 CST 2016, time=2016-12-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1844687, encodeId=0456184468ef4, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Mon May 22 03:53:00 CST 2017, time=2017-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934383, encodeId=14761934383c1, content=<a href='/topic/show?id=cfab9916818' target=_blank style='color:#2F92EE;'>#静脉窦血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99168, encryptionId=cfab9916818, topicName=静脉窦血栓)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11b4465, createdName=ying_wu, createdTime=Sun Jul 02 19:53:00 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741415, encodeId=ffa71e41415ab, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Sat Aug 19 09:53:00 CST 2017, time=2017-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697403, encodeId=7754169e403d9, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Fri May 12 00:53:00 CST 2017, time=2017-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618547, encodeId=0e20161854ec1, content=<a href='/topic/show?id=a95e9916698' target=_blank style='color:#2F92EE;'>#静脉窦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99166, encryptionId=a95e9916698, topicName=静脉窦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=237819898930, createdName=12498d2fm57(暂无昵称), createdTime=Fri Dec 23 04:53:00 CST 2016, time=2016-12-23, status=1, ipAttribution=)]
    2017-05-12 fusion
  5. [GetPortalCommentsPageByObjectIdResponse(id=1844687, encodeId=0456184468ef4, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Mon May 22 03:53:00 CST 2017, time=2017-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934383, encodeId=14761934383c1, content=<a href='/topic/show?id=cfab9916818' target=_blank style='color:#2F92EE;'>#静脉窦血栓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99168, encryptionId=cfab9916818, topicName=静脉窦血栓)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11b4465, createdName=ying_wu, createdTime=Sun Jul 02 19:53:00 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741415, encodeId=ffa71e41415ab, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Sat Aug 19 09:53:00 CST 2017, time=2017-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697403, encodeId=7754169e403d9, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Fri May 12 00:53:00 CST 2017, time=2017-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618547, encodeId=0e20161854ec1, content=<a href='/topic/show?id=a95e9916698' target=_blank style='color:#2F92EE;'>#静脉窦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99166, encryptionId=a95e9916698, topicName=静脉窦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=237819898930, createdName=12498d2fm57(暂无昵称), createdTime=Fri Dec 23 04:53:00 CST 2016, time=2016-12-23, status=1, ipAttribution=)]

相关资讯

古人如何清理血栓?这个办法同样适合现代人!

众所周知,血栓是威胁我们心脑血管健康的大敌。尤其是在秋冬二季,受寒冷气候、饮水减少、活动减少的影响,血栓更容易兴风作浪,导致动脉狭窄、血管堵塞,形成脑梗、心梗、下肢血管疾病。现代医学认为,血栓的形成是血液内的垃圾堆积所致。中医则认为,人体气不足,无法推动血液运行,久而久之形成血瘀,加上经络瘀阻,这才导致血栓。基于这样的认识,中医巨著《金匮要略》才记录了这样一款专门针对血栓性疾病的方子——复方黄芪粥

JACC:关于经导管主动脉瓣血栓形成,你了解多少?

目前,关于经导管主动脉瓣置换术(TAVR)后的经导管心脏瓣膜(THV)血栓形成的发生率,临床意义以及易感因素的数据都是有限的。来自丹麦的研究人员通过对比度增强的多层CT(MDCT)评估了TAVR后THV血栓形成的发生率,潜在预测因子和临床意义。在460例连续接受Edwards Sapien XT或Sapien 3 (Edwards Lifesciences, Irvine,  Calif

JACC:抗凝治疗可预防Fontan术后血栓和栓塞并发症

目前,房性心律失常成人患者接受Fontan手术后血栓和栓塞并发症(TEC)的风险数据有限。这项研究旨在确定这一人群TEC的风险,以及抗凝治疗在预防TEC中的作用。这是一项回顾性分析,该回顾性分析评估了在1994至2014年期间在梅奥诊所接受Fontan手术的房性心律失常患者的数据。TEC被分为2组:系统性TEC,定义为心内血栓,缺血性卒中或全身动脉栓塞;和非系统性TEC,定义为Fontan导管/右

JAMA子刊:创伤患者置入下腔静脉滤器,不能改善死亡率

因外伤入院的患者其出血和血栓形成风险均增加。这类患者中下腔静脉滤器(IVC)的使用一直在增加,但缺乏高质量的证据证明其疗效。这项回顾性队列研究采用分层3:1倾向匹配法,选择相似的患者安置下腔静脉滤器,多变量逻辑回归模型根据年龄、性别、种族/民族、损伤严重度评分等来计算倾向评分。根据受伤日期进行分层匹配。使用多变量逻辑回归分析比较两组住院死亡率,调整年龄、性别、种族/种族、损伤严重程度评分、头部和颈

世界血栓日,你动起来了吗?

血栓日由来:“血栓、栓塞、纤维蛋白原”的命名人德国的RudolfVirchow教授于1856年提出血栓形成三大要素:血管壁损伤、血流异常、血液成分异常。该理论至今仍被认可。2014年3月,国际血栓与止血学会(ISTH)宣布将RudolfVirchow生日(10月13日)作为“世界血栓日”,以纪念他首先提出“血栓形成”理论;并且通过这一活动提高公众对血栓性疾病的认知,促进血栓性疾病的规范诊治。201

感冒药可能导致肝衰竭?X射线安检仪危害大?真相是……

血栓抽吸装置问世,心脏支架将淘汰?吃感冒药可能导致肝衰竭?X射线安检仪危害大?这些10月的“科学”流言究竟靠不靠谱?真相在这里。1. 血栓抽吸装置问世,心脏支架被淘汰?流言:2016年7月1日起,台湾某医院发明一项新技术,可将血管内沉淀物吸出来,再也不用放支架了。资料图真相: 血栓,可以是从心脏某处脱落的,也可能是因为堵塞而凝固的。对于血栓,抽吸装置分两种:一种是手动的,一种是机械的。对